FDA.reportPublic FDA data

NDC 80673-001 - EBANGA

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
80673-001
Package NDCs from labels
80673-001-01, 80673-001-36
Manufacturer
Ridgeback Biotherapeutics, LP
Effective date
2025-02-10
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
EBANGA - Ridgeback Biotherapeutics, LPRidgeback Biotherapeutics, LP2025-02-10HUMAN PRESCRIPTION DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
80673-001-01EBANGA8 mL in 1 VIAL, SINGLE-DOSEINJECTION, POWDER, LYOPHILIZED,288 mL400 mg in 8mL5
80673-001-36EBANGA36 in 1 CARTONINJECTION, POWDER, LYOPHILIZED,400 mg in 8mL5

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
80673-001EBANGA (ANSUVIMAB) KIT [RIDGEBACK BIOTHERAPEUTICS, LP]5Unmatched20250212_9c008384-379d-48d3-b5a5-9809ed0f655c.zip